Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

UK orders millions more antivirals to help fight Omicron

With growing concerns over the spread of Omicron variant, the UK has signed two contracts with drug majors Pfizer Inc. and Merck & Co to buy 4.25 million courses of antivirals for the NHS patients.

The move is aimed at reducing hospitalisations and easing pressures on the NHS.


The two new contracts are for 1.75 million additional courses of Merck Sharp and Dohme’s (MSD) molnupiravir (Lagevrio®) and 2.5 million additional courses of PF-07321332/ritonavir (Paxlovid™) from Pfizer.

The ordered drugs will be available from early next year and both are expected to be effective against Omicron.

The recent order is in addition to the 480,000 courses of molnupiravir and 250,000 courses of PF-07321332/ritonavir procurement announced in October.

Sajid Javid Health secretary Sajid Javid

Commenting on the new contracts, health and social care secretary Sajid Javid, said: “This is a mammoth deal for the UK government and for patients across the country that are set to benefit from these antivirals over the coming months."

Javid said the latest move is to further efforts to bolster response to the virus “by ensuring access to the world’s best treatments”.

He further urged people aged 50 and over with an underlying health condition and tested positive for Covid-19 to sign up for the study and take advantage of this remarkable treatment.

Molnupiravir is already being rolled out to hundreds of patients through the national study PANORAMIC, run by the University of Oxford in close collaboration with GP hubs.

Targeting the virus at an early stage, antivirals are used to treat the infected people or protect exposed individuals from becoming infected.

Chair of the Antivirals Taskforce Eddie Gray said: “Both antivirals in our current portfolio could be vital tools against Omicron, with current evidence showing they will be effective against the variant.

The Antivirals Taskforce will continue its work to ensure vulnerable people who test positive for Covid-19 can rapidly access these medicines."

More For You

St James's University Hospital , NHS

Care Quality Commission downgraded the maternity and neonatal services at St James's University Hospital and Leeds General Infirmary.

Getty images

Two Leeds maternity units downgraded after inspection

The NHS regulator has downgraded two hospitals in Leeds to "inadequate" from "good" following an inspection.

The Care Quality Commission (CQC) said the maternity and neonatal services at Leeds General Infirmary (LGI) and St James' University Hospital of the Leeds Teaching Hospitals (LTH) NHS Trust posed "a significant risk" to women and babies.

Keep ReadingShow less
Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Primary care leaders join forces in effort to 'transform investment into primary care'

Community Pharmacy England (CPE) has teamed up with other national primary care bodies to urge the government to allocate more funds towards the sector.

In a joint statement released on the back of the government’s spending review, last week, the organisations welcomed the government’s continued determination to ‘shift care from hospitals to community and from sickness to prevention’ but warned that this would not be possible ‘without further investment in primary care’.

Keep ReadingShow less
Cancer patients warned against using weight-loss jabs

Macmillan Cancer Support said there is not enough evidence on how the weight-loss jabs might affect anti-cancer treatments.

iStock

Cancer patients warned against using weight-loss jabs

Cancer patients have been advised to consult their doctor before taking any weight-loss jabs.

Macmillan Cancer Support has issued this advisory following a surge in calls by cancer patients asking whether they can take fat loss jabs such as Wegovy and Mounjaro.

Keep ReadingShow less
Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology

The FLOWRx auto hub in the new Kamson warehouse in Uckfield.

Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology


Kamsons Pharmacy has announced that it has implemented a state-of-the-art hub and spoke dispensing model with the aim of freeing up more time to deliver clinical services.

Keep ReadingShow less
RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less